Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Couetoux Du Tertre, M."'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.
Autor: Gambaro K; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada.; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Marques M; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada., McNamara S; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada., Couetoux du Tertre M; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada., Hoffert C; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada.; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Srivastava A; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada.; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Schab A; Canadian National Centres of Excellence-Exactis Innovations, Montreal, QC H3T 1Y6, Canada.; Consortium de Recherche en Oncologie Clinique du Québec (Q-CROC), Quebec, QC G1V 3X8, Canada., Alcindor T; McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Langleben A; St. Mary's Hospital, Montreal, QC H3T 0A2, Canada., Sideris L; Hôpital Maisonneuve Rosemont, Montreal, QC H1T 2M4, Canada., Abdelsalam M; The Moncton Hospital, Moncton, NB E1C 6Z8, Canada., Tehfe M; Hematology-Oncology, Oncology Center-Centre Hospitalier de l'Université de Montreal, Montreal, QC H2X 0C1, Canada., Couture F; Hôtel-Dieu de Québec, Quebec, QC G1R 2J6, Canada., Batist G; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada., Kavan P; Segal Cancer Centre-Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 19; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 19.
Zobrazit plný text záznamu
5
Akademický článek
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancer.
Autor: Gambaro K; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada.; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Marques M; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada.; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., McNamara S; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada., Couetoux du Tertre M; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada., Diaz Z; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada., Hoffert C; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada.; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Srivastava A; Canadian National Centres of Excellence-Exactis Innovation, 5450 Cote-des-Neiges, Montreal, Quebec, H3T 1Y6, Canada.; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Hébert S; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Samson B; Charles LeMoyne Hospital, 3120 Taschereau Blvd., Greenfield Park, Quebec, J4V 2H1, Canada., Lespérance B; Sacré-Coeur de Montréal, 5400 Boul. Gouin O, Montreal, Quebec, H4J 1C5, Canada., Ko YJ; Sunnybrook Health Science Centre, 2075 Bayview Ave., Toronto, Ontario, M4N 3M5, Canada., Dalfen R; St. Mary's Hospital, 3830 Lacombe, Montreal, Quebec, H3T 1M5, Canada., St-Hilaire E; Georges Dumont Hospital, 220 Avenue Universite, Moncton, New Brunswick, E1C 2Z3, Canada., Sideris L; Hôpital Maisonneuve Rosemont, 5415 Assumption Blvd, Montreal, Quebec, H1T 2M4, Canada., Couture F; Hôtel-Dieu de Quebec, 11 Cote du Palais, Montreal, Quebec, G1R 2J6, Canada., Burkes R; Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, M5G 1X5, Canada., Harb M; Moncton Hospital, 135 Macbeath Ave, Moncton, New Brunswick, E1C 6Z8, Canada., Camlioglu E; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Gologan A; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Pelsser V; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Constantin A; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Greenwood CMT; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada.; Gerald Bronfman Department of Oncology, McGill University, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada.; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Tejpar S; Digestive Oncology Unit, Katholieke Universiteit Leuven, Oude Markt 13, Leuven, 3000, Belgium., Kavan P; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Kleinman CL; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada.; Department of Human Genetics, Lady Davis Research Institute, McGill University, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada., Batist G; McGill University-Segal Cancer Centre, Jewish General Hospital, 3755 Côte Ste-Catherine, Montreal, Quebec, H3T 1E2, Canada.
Publikováno v: Clinical and translational medicine [Clin Transl Med] 2021 Apr; Vol. 11 (4), pp. e401.
Zobrazit plný text záznamu
6
Akademický článek
Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data.
Autor: Blank-Landeshammer B; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany., Richard VR; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Mitsa G; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Marques M; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada., LeBlanc A; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Kollipara L; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany., Feldmann I; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany., Couetoux du Tertre M; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada., Gambaro K; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada., McNamara S; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada., Spatz A; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, and McGill University, Montreal, QC H4A3T2, Canada., Zahedi RP; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada., Sickmann A; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.; Medizinische Fakultät, Medizinisches Proteom-Center (MPC), Ruhr-Universität Bochum, 44801 Bochum, Germany.; Department of Chemistry, College of Physical Sciences, University of Aberdeen, Aberdeen AB243FX Scotland, UK., Batist G; Exactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.; Segal Cancer Centre, Lady Davis Institute, Jewish General Hospital, and McGill University, Montreal, QC H4A3T2, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A3T2, Canada., Borchers CH; Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.; Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University, Montreal, QC H4A3T2, Canada.
Publikováno v: Cancers [Cancers (Basel)] 2019 Dec 01; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje